{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:41:17Z","timestamp":1788536477591,"version":"build-2803163510"},"reference-count":154,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pathol.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T07:12:31Z","timestamp":1674198751000},"page":"302-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?"],"prefix":"10.1016","volume":"55","author":[{"given":"Faiha","family":"Fareez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-5569","authenticated-orcid":false,"given":"Jian-Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.01.002_bib1","article-title":"Impacts of NF1 gene mutations and genetic modifiers in neurofibromatosis type 1","volume":"12","author":"Wang","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.pathol.2023.01.002_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","article-title":"An update on the central nervous system manifestations of neurofibromatosis type 1","volume":"139","author":"Nix","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib5","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumour microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2023.01.002_bib6","first-page":"160","article-title":"An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age","volume":"77","author":"McKeever","year":"2008","journal-title":"Ulster Med J"},{"key":"10.1016\/j.pathol.2023.01.002_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fneur.2020.00368","article-title":"Sporadic and familial variants in NF1: an explanation of the wide variability in neurocognitive phenotype?","volume":"11","author":"Biotteau","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.pathol.2023.01.002_bib8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/DAD.0000000000000697","article-title":"Primary cutaneous follicular helper T-cell lymphoma in a patient with neurofibromatosis type 1: case report and review of the literature","volume":"39","author":"Shamsuyarova","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/neuonc\/nou329","article-title":"Akt- or MEK- mediated mTOR inhibition suppresses Nf1 optic glioma growth","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib13","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41375-018-0147-4","article-title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","volume":"32","author":"Eisfeld","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2023.01.002_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000001811","article-title":"Coincidental expression of classic Hodgkin lymphoma and neurofibromatosis type 1 and literature review","volume":"43","author":"Cabrera","year":"2021","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib15","article-title":"An unusual association between neurofibromatosis type 1 and diffuse B cell lymphoma","author":"Bizanti","year":"2021","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pde.13094","article-title":"Cutaneous and systemic findings in mosaic neurofibromatosis type 1","volume":"34","author":"V\u00e1zquez-Osorio","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000456029","article-title":"T-cell lymphoma in a patient with neurofibromatosis type 1 and AIDS","volume":"10","author":"De Castro","year":"2017","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib18","first-page":"123","article-title":"Primary effusion lymphoma-like lymphoma in a patient with neurofibromatosis type 1","volume":"41","author":"Oki","year":"2016","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cge.12625","article-title":"Neurofibromatosis type 1 and malignancy in childhood","volume":"89","author":"Varan","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/his.12810","article-title":"Intra-abdominal ALK-positive anaplastic large cell lymphoma in a patient with neurofibromatosis type 1","volume":"68","author":"Agaimy","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.002_bib21","article-title":"Severe hypercholesterolemia: a unique presentation of non-Hodgkin's lymphoma in a patient with neurofibromatosis type 1","volume":"1","author":"Chudy-Onwugaje","year":"2014","journal-title":"Case Rep Gastrointest Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib22","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.3747\/co.21.1803","article-title":"Fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies","volume":"21","author":"De Blank","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pathol.2023.01.002_bib23","first-page":"266","article-title":"Oncologic manifestations in children with neurofibromatosis type 1 in Turkey","volume":"55","author":"\u0130ncecik","year":"2013","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.pathol.2023.01.002_bib24","first-page":"42","article-title":"Malignancies in Chinese patients with neurofibromatosis type 1","volume":"19","author":"Cheuk","year":"2013","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.pathol.2023.01.002_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1752-1947-6-8","article-title":"Diffuse large B cell lymphoma presenting as Horner\u2019s syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature","volume":"6","author":"Lueangarun","year":"2012","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.pathol.2023.01.002_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0b013e318248e59c","article-title":"A\u00a021-year-old woman with multiple cancers and a new brain lesion","volume":"78","author":"Schiff","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pathol.2023.01.002_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10072-011-0886-8","article-title":"Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease)","volume":"33","author":"Eoli","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.pathol.2023.01.002_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.prp.2009.07.003","article-title":"An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and Von Recklinghausen's neurofibromatosis","volume":"206","author":"Rampisela","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2023.01.002_bib29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humpath.2008.09.003","article-title":"Gaucher or Pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient","volume":"40","author":"Cajaiba","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/opge.25.1.49.29005","article-title":"Neurofibromatosis type 1 associated with central nervous system lymphoma","volume":"25","author":"Zein","year":"2004","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mpo.10423","article-title":"Neurofibromatosis type 1 and multiple primary malignancies","volume":"41","author":"Barbaric","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3904\/kjim.2003.18.3.202","article-title":"A\u00a0case of non-Hodgkin's lymphoma in a patient with neurofibromatosis type 1","volume":"18","author":"Kim","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib33","first-page":"145","article-title":"Subcutaneous panniculitis-like T-cell lymphoma in type 1 neurofibromatosis: a case report","volume":"22","author":"Reich","year":"2014","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.pathol.2023.01.002_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1620\/tjem.208.169","article-title":"Diffuse large B-cell lymphoma arising in a patient with neurofibromatosis type I and in a patient with neurofibromatosis type II","volume":"208","author":"Dohi","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib35","first-page":"27","article-title":"Cutaneous T-cell lymphoma in a patient with neurofibromatosis type 1","volume":"72","author":"Herbert","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.pathol.2023.01.002_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-4362.2002.14472.x","article-title":"Neurofibromatosis type 1 and mycosis fungoides","volume":"41","author":"Braam","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0190-9622(08)80700-1","article-title":"Coexistence of late onset neurofibromatosis and cutaneous T cell lymphoma","volume":"23","author":"Trattner","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jama.1977.03270370065026","article-title":"Burkitt lymphoma in a patient with neurofibromatosis and pheochromocytoma","volume":"237","author":"Berman","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2023.01.002_bib39","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1 gene product","volume":"88","author":"Gutmann","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2023.01.002_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/neu.480270408","article-title":"Regulated expression of neurofibromin in migrating neural crest cells of avian embryos","volume":"27","author":"Stocker","year":"1995","journal-title":"J\u00a0Neurobiol"},{"key":"10.1016\/j.pathol.2023.01.002_bib41","series-title":"Neurofibromatosis: Phenotype, Natural History and Pathogenesis","first-page":"119","article-title":"The structure and function of the NF1 gene: molecular pathophysiology","author":"Viskochil","year":"1999"},{"key":"10.1016\/j.pathol.2023.01.002_bib42","first-page":"315","article-title":"Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues","volume":"6","author":"Gutmann","year":"1995","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.pathol.2023.01.002_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jmb.2006.11.055","article-title":"The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex","volume":"366","author":"Welti","year":"2007","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.pathol.2023.01.002_bib44","doi-asserted-by":"crossref","first-page":"16409","DOI":"10.1074\/jbc.271.27.16409","article-title":"Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin","volume":"271","author":"Ahmadian","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2023.01.002_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins","volume":"63","author":"Ballester","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2023.01.002_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/351576a0","article-title":"Differential regulation of rasGAP and neurofibromatosis gene product activities","volume":"351","author":"Bollag","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2023.01.002_bib47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2023.01.002_bib48","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1126\/science.2821624","article-title":"A\u00a0cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants","volume":"238","author":"Trahey","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.pathol.2023.01.002_bib49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2023.01.002_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.24783","article-title":"Preclinical in\u00a0vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft","volume":"126","author":"Bhola","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib51","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumour suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2023.01.002_bib52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.055772","article-title":"Clinical and molecular aspects of RAS related disorders","volume":"45","author":"Denayer","year":"2008","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pathol.2023.01.002_bib54","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/onc.2016.464","article-title":"The primacy of NF1 loss as the driver of tumourigenesis in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Pemov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2023.01.002_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","article-title":"Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis","volume":"5","author":"Laycock-van Spyk","year":"2011","journal-title":"Hum Genomics"},{"key":"10.1016\/j.pathol.2023.01.002_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/302747","article-title":"Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1","volume":"66","author":"Eisenbarth","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jmg.37.1.44","article-title":"A\u00a0search for evidence of somatic mutations in the NF1 gene","volume":"37","author":"John","year":"2000","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0996-110","article-title":"Identification of NF1 mutations in both alleles of a dermal neurofibroma","volume":"14","author":"Sawada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib59","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib60","first-page":"284","article-title":"Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants","volume":"42","author":"Riccardi","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib61","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/gtmb.2014.0109","article-title":"The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study","volume":"18","author":"Maruoka","year":"2014","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.pathol.2023.01.002_bib62","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7326\/0003-4819-144-11-200606060-00010","article-title":"Pathophysiology of neurofibromatosis type 1","volume":"144","author":"Theos","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pathol.2023.01.002_bib64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jocn.2018.04.006","article-title":"Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours","volume":"53","author":"Prasad","year":"2018","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.pathol.2023.01.002_bib65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajhg.2017.06.004","article-title":"From peas to disease: modifier genes, network resilience, and the genetics of health","volume":"101","author":"Riordan","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib67","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pathol.2023.01.002_bib68","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM199411243312102","article-title":"Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father","volume":"331","author":"Lazaro","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0022-202X.2005.23834.x","article-title":"Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1","volume":"125","author":"Consoli","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib70","first-page":"244","article-title":"Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5)","volume":"2","author":"Boltshauser","year":"1989","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.pathol.2023.01.002_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1994.tb06893.x","article-title":"What is segmental neurofibromatosis?","volume":"130","author":"Moss","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","article-title":"A\u00a0prospective study of neurofibromatosis type 1 cancer incidence in the UK","volume":"95","author":"Walker","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib73","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","article-title":"Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989","volume":"19","author":"Evans","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib74","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13023-021-01856-8","article-title":"Lymphoproliferative malignancies in patients with neurofibromatosis 1","volume":"16","author":"Bergqvist","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pathol.2023.01.002_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/cns-2016-0024","article-title":"The role of the immune system in neurofibromatosis type 1-associated nervous system tumours","volume":"6","author":"Karmakar","year":"2017","journal-title":"CNS Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib76","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00262-011-1104-5","article-title":"Dual biological effects of the cytokines interleukin-10 and interferon-gamma","volume":"60","author":"Wilke","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.pathol.2023.01.002_bib77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumour microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib78","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib79","first-page":"13","article-title":"The human mast cell: an overview","volume":"315","author":"Krishnaswamy","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pathol.2023.01.002_bib80","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2023.01.002_bib81","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-012-1056-7","article-title":"Neurofibroma-associated macrophages play roles in tumour growth and response to pharmacological inhibition","volume":"125","author":"Prada","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib83","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1172\/JCI99424","article-title":"Contributions of inflammation and tumour microenvironment to neurofibroma tumourigenesis","volume":"128","author":"Liao","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2023.01.002_bib84","first-page":"237","article-title":"The ultrastructure of schwannoma and neurofibroma of the peripheral nerves","volume":"17","author":"Sanguinetti","year":"1991","journal-title":"Ital J Orthop Traumatol"},{"key":"10.1016\/j.pathol.2023.01.002_bib85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1083\/jcb.111.2.645","article-title":"Angiogenic and invasive properties of neurofibroma Schwann cells","volume":"111","author":"Sheela","year":"1990","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.pathol.2023.01.002_bib86","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1097-0142(196605)19:5<699::AID-CNCR2820190516>3.0.CO;2-H","article-title":"Ultrastructure of benign peripheral nerve sheath tumours","volume":"19","author":"Waggener","year":"1966","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib87","first-page":"261","article-title":"100 protein in soft-tissue tumours derived from Schwann cells and melanocytes","volume":"106","author":"Stefansson","year":"1982","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K","article-title":"Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma","volume":"24","author":"Kluwe","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib89","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/ddl165","article-title":"Nf1+\/\u2212 mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling","volume":"15","author":"Yang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib90","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","article-title":"Neurofibromatosis Type 1 and tumourigenesis: molecular mechanisms and therapeutic implications","volume":"28","author":"Gottfried","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.pathol.2023.01.002_bib91","first-page":"5113","article-title":"A\u00a0neurogenic tumour containing a low-grade malignant peripheral nerve sheath tumour (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A\/p16: a case report showing progression from a neurofibroma to a high-grade MPNST","volume":"8","author":"Tajima","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2023.01.002_bib92","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-11-4092","article-title":"PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumours","volume":"72","author":"Keng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib93","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumour development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pathol.2023.01.002_bib94","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen","year":"2008","journal-title":"Curr Biol"},{"key":"10.1016\/j.pathol.2023.01.002_bib95","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/MCB.01153-08","article-title":"Ral overactivation in malignant peripheral nerve sheath tumours","volume":"29","author":"Bodempudi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pathol.2023.01.002_bib96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ccr.2009.05.009","article-title":"Proteasomal and genetic inactivation of the NF1 tumour suppressor in gliomagenesis","volume":"16","author":"McGillicuddy","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2023.01.002_bib97","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pathol.2023.01.002_bib98","first-page":"1239","article-title":"Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation","volume":"57","author":"Yeh","year":"2009","journal-title":"OPAC"},{"key":"10.1016\/j.pathol.2023.01.002_bib99","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib100","series-title":"WHO Classification of Tumours Series","article-title":"Central nervous system tumours","year":"2021"},{"key":"10.1016\/j.pathol.2023.01.002_bib101","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1093\/hmg\/ddu389","article-title":"Neuronal NF1\/RAS regulation of cyclic AMP requires atypical PKC activation","volume":"23","author":"Anastasaki","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib102","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1158\/0008-5472.CAN-09-3769","article-title":"Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1","volume":"70","author":"Warrington","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib103","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/ajmg.a.35560","article-title":"Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area","volume":"158","author":"Wang","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pathol.2023.01.002_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jmg.2007.049346","article-title":"Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening","volume":"44","author":"Sharif","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib105","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","article-title":"Increased risk of breast cancer in women with NF1","volume":"158A","author":"Madanikia","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pathol.2023.01.002_bib106","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.2015.78","article-title":"Age-specific risk of breast cancer in women with neurofibromatosis type 1","volume":"112","author":"Seminog","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib107","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/0008-5472.CAN-16-1586","article-title":"A\u00a0transposon-based analysis reveals RASA1 is involved in triple-negative breast cancer","volume":"77","author":"Su\u00e1rez-Cabrera","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1534\/genetics.112.142802","article-title":"Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver","volume":"192","author":"Wallace","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.pathol.2023.01.002_bib109","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited - from bench to bedside","volume":"15","author":"Yap","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2023.01.002_bib110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cancergencyto.2004.04.019","article-title":"A\u00a0case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer","volume":"156","author":"Guran","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2023.01.002_bib111","first-page":"1","article-title":"Metaplastic breast cancer in a patient with neurofibromatosis","volume":"5","author":"Chaudhry","year":"2015","journal-title":"J\u00a0Clin Imaging Sci"},{"key":"10.1016\/j.pathol.2023.01.002_bib112","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/1097-0142(19931101)72:9<2746::AID-CNCR2820720936>3.0.CO;2-W","article-title":"Neurofibromatosis type 1 and childhood cancer","volume":"72","author":"Matsui","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmg.2015.12.008","article-title":"Preexisting conditions in pediatric ALL patients: spectrum, frequency and clinical impact","volume":"59","author":"Sch\u00fctte","year":"2016","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib114","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/sj.onc.1210361","article-title":"Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11","volume":"26","author":"Flotho","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2023.01.002_bib115","first-page":"441","article-title":"Chronic lymphocytic leukemia associated with von Recklinghausen neurofibromatosis","volume":"54","author":"Sanada","year":"1991","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2023.01.002_bib116","first-page":"129","article-title":"An unusual manifestation in a patient with neurofibromatosis type 1","volume":"151","author":"Miraglia","year":"2016","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.pathol.2023.01.002_bib117","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1073\/pnas.0903091106","article-title":"Acquired copy number alterations in adult acute myeloid leukemia genomes","volume":"106","author":"Walter","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2023.01.002_bib118","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1158\/1078-0432.CCR-09-2639","article-title":"NF1 inactivation in adult acute myelogenous leukemia","volume":"16","author":"Parkin","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib119","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-07-1005","article-title":"Targeting Ras in myeloid leukemias","volume":"14","author":"Braun","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib120","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41375-018-0147-4","article-title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","volume":"32","author":"Eisfeld","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2023.01.002_bib121","first-page":"260","article-title":"Xantholeucemie due nourisson et neurofibormatose de Recklinghausen","volume":"5","author":"Royer","year":"1958","journal-title":"Ann Pediatr"},{"key":"10.1016\/j.pathol.2023.01.002_bib122","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0022-3476(78)80362-X","article-title":"Neurofibromatosis and childhood leukemia","volume":"92","author":"Bader","year":"1978","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pathol.2023.01.002_bib123","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020","volume":"4","author":"Landry","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pathol.2023.01.002_bib124","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1074\/jbc.M009202200","article-title":"Neurofibromin GTPase- activating protein-related domains restore normal growth in Nf1\u2212\/\u2212 cells","volume":"276","author":"Hiatt","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2023.01.002_bib125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"NF1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia","volume":"12","author":"Largaespada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2023.01.002_bib126","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.187.11.1893","article-title":"Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines","volume":"187","author":"Zhang","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib127","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","article-title":"Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras","volume":"84","author":"Kalra","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.01.002_bib128","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.3390\/ijms21186623","article-title":"Molecular pathogenesis of Hodgkin lymphoma: past, present, future","volume":"21","author":"Bienz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2023.01.002_bib129","series-title":"StatPearls. Treasure island","article-title":"Non-Hodgkin lymphoma","author":"Sapkota","year":"2022"},{"key":"10.1016\/j.pathol.2023.01.002_bib130","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2217\/fon.13.113","article-title":"Signaling pathways in lymphoma: pathogenesis and therapeutic targets","volume":"9","author":"Arita","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib131","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib132","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2023.01.002_bib133","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","article-title":"B\u00a0cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor","volume":"21","author":"Chiorazzi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pathol.2023.01.002_bib134","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.01.002_bib135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signaling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2023.01.002_bib136","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib137","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin\u2019s lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib138","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2023.01.002_bib139","first-page":"58","article-title":"Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies","volume":"1865","author":"Xia","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pathol.2023.01.002_bib140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.pathol.2023.01.002_bib141","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.01.002_bib142","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.01.002_bib143","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","article-title":"High numbers of tumour-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma","volume":"27","author":"Carreras","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib144","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3324\/haematol.2012.077537","article-title":"The PD-1\/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia","volume":"98","author":"Brusa","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2023.01.002_bib145","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00262-016-1871-0","article-title":"Effector T cell subclasses associate with tumour burden in neurofibromatosis type 1 patients","volume":"65","author":"Farschtschi","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.pathol.2023.01.002_bib146","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2002-03-0734","article-title":"Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function","volume":"100","author":"Ingram","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.01.002_bib147","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0161-5890(01)00101-8","article-title":"Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin","volume":"38","author":"Kim","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pathol.2023.01.002_bib148","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3389\/fimmu.2017.01901","article-title":"Neurofibromin 1 impairs natural killer T-cell-dependent antitumour immunity against a T-cell lymphoma","volume":"8","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2023.01.002_bib149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1084\/jem.184.1.9","article-title":"Positive and negative selection invoke distinct signaling pathways","volume":"184","author":"Alberola-Ila","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2023.01.002_bib150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2013.00178","article-title":"Regulation of lipid signaling by diacylglycerol kinases during T cell development and function","volume":"4","author":"Krishna","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2023.01.002_bib151","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.4049\/jimmunol.175.7.4301","article-title":"Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK","volume":"175","author":"Renukaradhya","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2023.01.002_bib152","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/IAI.01307-09","article-title":"Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the ERK1\/2 MAPK pathway","volume":"78","author":"Khan","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.pathol.2023.01.002_bib153","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mpo.2950240110","article-title":"Consecutive glioblastoma and B cell non-Hodgkin\u2019s lymphoma in a young child with von Recklinghausen\u2019s neurofibromatosis","volume":"24","author":"Uyttebroeck","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.pathol.2023.01.002_bib154","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00001622-200009000-00002","article-title":"Epidemiology of lymphomas","volume":"12","author":"Baris","year":"2000","journal-title":"Curr Opin Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T19:03:09Z","timestamp":1678129389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":154,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0031302523000302"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}